Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Harmonix Fund
AddedFeb 13, 2024
UpdatedJun 28, 2026
Harmonix Fund

Harmonix Fund

Operating

Venture capital fund specializing in HealthTech, AutoTech, and ManufacturingTech startups, with a focus on sustainability and impact.

Location
Los Angeles, CA, US
Founded
2017
Firm
Compare
Portfolio
Employees
Website

Harmonix Fund is a science-driven, early-stage venture capital firm focusing on healthcare, life sciences, and deep tech sectors. The fund invests in technological breakthroughs that contribute to a healthy, operational, and peaceful civilization. Harmonix typically participates in seed and Series A rounds, with occasional investments in later stages.

The fund's portfolio includes notable companies such as Insilico Medicine, Caresyntax, and Momentus. Harmonix's multi-disciplinary team comprises scientists, researchers, operators, and entrepreneurs, providing unique value to portfolio companies. The firm emphasizes sustainability and impact, particularly in HealthTech, AutoTech, and ManufacturingTech startups.

Harmonix Fund - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments42
Current Portfolio Count32
Total Portfolio Exits0

Top Investment Stages

Seed14 (35.0%)
Series A11 (27.5%)
Series Unknown8 (20.0%)
Series B5 (12.5%)
Series C2 (5.0%)

Stage Mix

Seed 35%Series A 28%Series Unknown 20%Series B 13%Series C 5%

Concentration shown as share of disclosed investments by stage.

Recent Investments

SentiAR logo

SentiAR

Atlas Space Operations logo

Atlas Space Operations

Caresyntax logo

Caresyntax

Attivare Therapeutics logo

Attivare Therapeutics

Sorcero logo

Sorcero

xCures logo

xCures

Strateos logo

Strateos

Sana Health logo

Sana Health

Scribe Biosciences logo

Scribe Biosciences

Visicell Medical logo

Visicell Medical

Aether Bio logo

Aether Bio

Pathology Watch logo

Pathology Watch

Auransa logo

Auransa

RAD AI logo

RAD AI

Ancilia Biosciences logo

Ancilia Biosciences

Juvena Therapeutics logo

Juvena Therapeutics

Bioz logo

Bioz

Viscient Bio logo

Viscient Bio

Pragma Biosciences logo

Pragma Biosciences

Nelumbo logo

Nelumbo

Prime Movers Lab logo

Prime Movers Lab

Abalone Bio logo

Abalone Bio

Tarana Wireless logo

Tarana Wireless

GEn1E Lifesciences logo

GEn1E Lifesciences

Mathison logo

Mathison

Harmonix Fund - Similar Investment Firms

Harmonic Future logo

Harmonic Future

Harmony Partners logo

Harmony Partners

harmonyvp.com

Harmonic Growth Partners logo

Harmonic Growth Partners

harmonicgp.com

Narrative Fund logo

Narrative Fund

Targeted Technology Fund logo

Targeted Technology Fund

targetedtech.com

H Venture Partners logo

H Venture Partners

h.ventures

HC9 Ventures logo

HC9 Ventures

hc9.vc

Ensemble Labs logo

Ensemble Labs

ensemblelabs.com

Beta Fund logo

Beta Fund

FundRx logo

FundRx

mbxcapital.com

OpAmp Capital logo

OpAmp Capital

SeedFolio logo

SeedFolio

Wavemaker Three-Sixty Health logo

Wavemaker Three-Sixty Health

wavemaker360.com

Fellows Fund logo

Fellows Fund

fellowsfundvc.com

Tech Pioneers Fund logo

Tech Pioneers Fund

Harmonix Fund - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end